CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...
Phase 4
New Haven, Connecticut, United States and 65 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Hawthorne, New York, United States and 335 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Hawthorne, New York, United States and 142 other locations
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...
Phase 2
New Haven, Connecticut, United States and 133 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Hawthorne, New York, United States and 74 other locations
This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...
Phase 4
Hawthorne, New York, United States of America and 77 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Hawthorne, New York, United States and 394 other locations
MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...
Phase 3
Hawthorne, New York, United States and 137 other locations
adults (do not have disease) and or in adults with mild-to-moderate asthma. This is the first time the study medicine is being given to peop...
Phase 1
New Haven, Connecticut, United States
The objectives of this clinical trial are to evaluate the safety and tolerability of topically applied ATR12-351, to understand what the body does to...
Phase 1
New Haven, Connecticut, United States and 1 other location
Clinical trials
Research sites
Resources
Legal